{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:27:38Z","timestamp":1794868058393,"version":"4.9.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Limitations still exist in the surgical strategies for primary aldosteronism (PA), the most common cause of secondary hypertension. This study aimed to compare the effectiveness of\n                      <jats:sup>68<\/jats:sup>\n                      Ga-pentixafor PET\/CT versus adrenal venous sampling (AVS) in guiding surgical management for PA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>\n                      A prospective cohort of 197 PA patients were assigned to Group PET (n = 137) and Group AVS (n = 60), in which the surgical interventions were guided by\n                      <jats:sup>68<\/jats:sup>\n                      Ga-pentixafor PET\/CT and AVS, respectively. Postoperative clinical and biochemical outcomes were analyzed referring to Primary Aldosteronism Surgical Outcomes classification system, with subgroup analysis on clinical characteristics and outcomes conducted in Group PET.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      During a median follow-up of 27 (16, 39) months, the postoperative clinical and biochemical outcomes were comparable between 134 patients in Group PET and 57 patients in Group AVS, with unilateral or bilateral adrenal lesions. The rates of complete, partial, and absent clinical success were 51.5%, 38.1%, 10.4% in Group PET, and 35.1%, 50.9%, 14.0% in Group AVS (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.115). For biochemical success, the corresponding rates were 82.1%, 12.7%, 5.2% in Group PET, and 75.4%, 17.5%, 7.0% in Group AVS (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.533). The proportion of complete biochemical success was significantly higher than that of complete clinical success (80.10% vs 46.6%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Female gender was associated with increased likelihood of complete clinical and biochemical success, and lower preoperative systolic blood pressure and shorter duration of hypertension indicated increased likelihood of complete clinical success. The SUV\n                      <jats:sub>max<\/jats:sub>\n                      was significantly correlated with lesion diameters, age, duration of hypertension, blood potassium level, pathological type and clinical outcomes. A cutoff value of 5.5 for SUV\n                      <jats:sub>max<\/jats:sub>\n                      demonstrated a sensitivity of 82.8% and a specificity of 92.6% in identifying functional adrenal lesions with autonomous aldosterone secretion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      <jats:sup>68<\/jats:sup>\n                      Ga-pentixafor PET\/CT demonstrated potential non-inferiority to AVS in guiding the surgical management for PA patients, with comparable postoperative clinical and biochemical outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003483","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T15:00:18Z","timestamp":1757602818000},"page":"844-853","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["68Ga-pentixafor PET\/CT versus adrenal venous sampling in guiding surgical management for primary aldosteronism: a prospective cohort study on postoperative outcomes"],"prefix":"10.1097","volume":"112","author":[{"given":"Guoyang","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjie","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchun","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenda","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8058-9702","authenticated-orcid":false,"given":"Yushi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anli","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"R1-20260518","doi-asserted-by":"crossref","first-page":"1811\u201320","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R2-20260518","doi-asserted-by":"crossref","first-page":"1889\u2013916","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-20260518","doi-asserted-by":"crossref","first-page":"665\u201372","DOI":"10.1111\/cen.13442","article-title":"Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism","volume":"87","author":"Nanba","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R4-20260518","doi-asserted-by":"crossref","first-page":"641\u201349","DOI":"10.1161\/HYPERTENSIONAHA.118.11382","article-title":"Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism","volume":"72","author":"Williams","year":"2018","journal-title":"Hypertension"},{"key":"R5-20260518","doi-asserted-by":"crossref","first-page":"dgz017","DOI":"10.1210\/clinem\/dgz017","article-title":"Subtyping of primary aldosteronism in the AVIS-2 study: assessment of selectivity and lateralization","volume":"105","author":"Rossitto","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20260518","doi-asserted-by":"crossref","first-page":"317\u201325","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension"},{"key":"R7-20260518","doi-asserted-by":"crossref","first-page":"2656\u201365","DOI":"10.1007\/s00259-020-04722-0","article-title":"Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism","volume":"47","author":"Ding","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-20260518","doi-asserted-by":"crossref","first-page":"368\u201375","DOI":"10.2967\/jnumed.121.261964","article-title":"Functional characterization of adrenocortical masses in nononcologic patients using 68Ga-pentixafor","volume":"63","author":"Ding","year":"2022","journal-title":"J Nucl Med"},{"key":"R9-20260518","first-page":"996\u20131003","article-title":"Functional nodules in primary aldosteronism: identification of CXCR4 expression with 68Ga-pentixafor PET\/CT","volume":"33","author":"Gao","year":"2023","journal-title":"Eur Radiol"},{"key":"R10-20260518","doi-asserted-by":"crossref","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","article-title":"Accuracy of gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism","volume":"6","author":"Hu","year":"2023","journal-title":"JAMA Network Open"},{"key":"R11-20260518","first-page":"100081","article-title":"Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of artificial intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R12-20260518","doi-asserted-by":"crossref","first-page":"689\u201399","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Primary aldosteronism surgery outcome (PASO) investigators. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R13-20260518","doi-asserted-by":"crossref","first-page":"453\u201363","DOI":"10.1007\/s00268-017-4311-1","article-title":"Refining the definitions of biochemical and clinical cure for primary aldosteronism using the primary aldosteronism surgical outcome (PASO) classification system","volume":"42","author":"Miller","year":"2018","journal-title":"World J Surg"},{"key":"R14-20260518","doi-asserted-by":"crossref","first-page":"1\u201315","DOI":"10.7326\/0003-4819-44-1-1","article-title":"Primary aldosteronism, a new clinical entity","volume":"44","author":"Conn","year":"1956","journal-title":"Ann Intern Med"},{"key":"R15-20260518","doi-asserted-by":"crossref","first-page":"578\u201389","DOI":"10.1038\/s41574-020-0382-4","article-title":"Pathogenesis and treatment of primary aldosteronism","volume":"16","author":"Zennaro","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"R16-20260518","doi-asserted-by":"crossref","first-page":"739\u201346","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R17-20260518","doi-asserted-by":"crossref","first-page":"e14438","DOI":"10.1111\/ijcp.14438","article-title":"Adrenal venous sampling with adrenocorticotropic hormone stimulation: a meta-analysis","volume":"75","author":"Yang","year":"2021","journal-title":"Int J Clin Pract"},{"key":"R18-20260518","doi-asserted-by":"crossref","first-page":"329\u201337","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"R19-20260518","doi-asserted-by":"crossref","first-page":"171\u201382","DOI":"10.1210\/clinem\/dgad421","article-title":"The value of targeting CXCR4 with 68Ga-Pentixafor PET\/CT for subtyping primary aldosteronism","volume":"109","author":"Zheng","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20260518","doi-asserted-by":"crossref","first-page":"1291775","DOI":"10.3389\/fendo.2024.1291775","article-title":"A comparison of the performance of 68Ga-Pentixafor PET\/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism","volume":"15","author":"Yin","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R21-20260518","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13550-024-01125-2","article-title":"Clinical value of 68Ga-pentixafor PET\/CT in patients with primary aldosteronism and bilateral lesions: preliminary results of a single-centre study","volume":"14","author":"Zuo","year":"2024","journal-title":"EJNMMI Res"},{"key":"R22-20260518","first-page":"100384","article-title":"68Ga-pentixafor PET\/CT in guiding surgical management of primary aldosteronism","volume":"39","author":"Zheng","year":"2025","journal-title":"J Clin Transl Endocrinol"},{"key":"R23-20260518","doi-asserted-by":"crossref","first-page":"681\u2013700","DOI":"10.1016\/j.ecl.2019.08.002","article-title":"Primary aldosteronism diagnosis and management: a clinical approach","volume":"48","author":"Hundemer","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R24-20260518","doi-asserted-by":"crossref","first-page":"1578\u201382","DOI":"10.1016\/j.juro.2010.12.051","article-title":"Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma","volume":"185","author":"Fu","year":"2011","journal-title":"J Urol"},{"key":"R25-20260518","doi-asserted-by":"crossref","first-page":"100\u201304","DOI":"10.1016\/j.mce.2017.08.019","article-title":"Aberrant G protein-receptor expression is associated with DNA methylation in aldosterone-producing adenoma","volume":"461","author":"Itcho","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"R26-20260518","doi-asserted-by":"crossref","first-page":"2338242","DOI":"10.1080\/07853890.2024.2338242","article-title":"Outpatient management of essential hypertension: a review based on the latest clinical guidelines","volume":"56","author":"Moiz","year":"2024","journal-title":"Ann Med"},{"key":"R27-20260518","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11883-016-0632-z","article-title":"The different facets of dyslipidemia and hypertension in atherosclerosis","volume":"18","author":"Hurtubise","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"R28-20260518","first-page":"155\u201396","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:18:49Z","timestamp":1779110329000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003483","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"2025-04-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}